Friday 6 November 2026 Export CORT’s income statement to Excel — free account

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.

Revenue: +64.0%
EPS: +525.8%
Free cash flow: +161.0%

Quarter to September 2026, against a year earlier

72.63 1.00 +1.40%

Follow CORT

Alert me

Market cap: $7.8B
P/E: 47.5×
Fwd P/E: 39.8×
Dividend yield: —
F-score: 4/9
Altman Z: 14.11
Beneish M: −2.76
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	4	5	5	7
ROE Full definition →		14.79%	7.07%	8.08%	21.74%
ROA Full definition →		11.71%	5.62%	6.41%	17.16%
ROIC Full definition →		9.98%	(1.71%)	1.01%	14.97%
Return on Tangible Assets Full definition →		30.56%	16.67%	18.63%	44.12%
Average Days of Receivables Full definition →		28.66	18.54	33.79	42.07
Free Cash Flow per Share Full definition →		1.37	1.15	1.01	1.83
Free Cash Flow Full definition →		141.79	120.15	106.92	194.62
Capital Expenditures Full definition →		(0.21)	(0.31)	(2.78)	(3.49)
Other line items
Cash ROIC Full definition →		13.83%	12.31%	10.54%	16.16%
Accounts Receivable Turnover Full definition →		13.39	15.25	11.74	10.67
Accounts Payable Turnover Full definition →		0.47	0.44	0.73	0.50
Inventory Turnover Full definition →		1.03	0.99	1.11	1.16
Average Days of Payables Full definition →		1,137.56	903.37	386.38	567.66
Days of Inventory on Hand Full definition →		361.93	349.62	341.68	308.30
Tax Rate Full definition →		0.50	2.90	1.09	0.23
Research and Development Expense of Revenue Full definition →		33.48%	33.86%	30.56%	25.08%
Selling, General and Administrative Expense of Revenue Full definition →		58.93%	65.46%	66.98%	61.94%
Share Based Compensation of Revenue Full definition →		11.10%	11.14%	11.57%	10.65%
Operating CF/Net income Full definition →		1.45	2.58	2.02	1.24
Depreciation/Fixed assets Full definition →		(1.70)	(0.97)	(0.52)	(0.43)
Capex/Depreciation Full definition →		0.07	0.10	1.04	1.63
Revenue per Share Full definition →		7.33	7.36	7.88	9.04
Operating CF per Share Full definition →		1.37	1.15	1.04	1.86
Capex per Share Full definition →		0.00	0.00	(0.03)	(0.03)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly